Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$480,034
-$79,740 QoQ
Shares Held
19,935
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,787
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026One Capital Management, LLC holds $33,369,711 across 9 Drug Manufacturers - General names. PFE ranks #6 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
160,540 | $20,629,390 | |
| 2 | LLY |
ELI LILLY & Co
|
3,238 | $3,883,754 | |
| 3 | JNJ |
Johnson & Johnson
|
14,466 | $3,673,930 | |
| 4 | ABBV |
AbbVie Inc.
|
12,155 | $3,058,684 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
5,067 | $640,164 | |
| 6 | PFE |
Pfizer Inc
This page
|
19,935 | $480,034 | |
| 7 | NVO |
Novo Nordisk A S
|
9,298 | $445,746 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,291 | $304,867 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $480,034 | 19,935 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $559,774 | 19,935 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $891,718 | 35,812 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $9,958,526 | 390,837 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,748,337 | 360,905 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $8,245,281 | 325,386 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,999,352 | 301,521 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $8,919,018 | 308,190 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,573,654 | 270,681 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $5,690,137 | 205,050 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $5,262,639 | 182,794 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $6,310,393 | 190,244 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $6,572,102 | 179,174 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,795,852 | 166,565 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $7,681,029 | 149,903 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $6,535,468 | 149,348 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,500,059 | 143,049 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,480,454 | 144,494 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $8,476,273 | 143,544 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $5,970,863 | 138,825 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,684,152 | 145,152 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,804,098 | 132,600 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,286,745 | 116,456 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,935,594 | 107,237 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $3,458,192 | 105,755 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $3,209,747 | 98,338 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||